🇺🇸 Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation

by

🇺🇸

Bagsværd, Denmark, 31 July 2026 – Novo Nordisk today announced headline results from the ZEUS cardiovascular outcomes phase 3 trial.

Source: globenewswire

Country: United States